Analyze Diet
Emerging microbes & infections2020; 9(1); 651-663; doi: 10.1080/22221751.2020.1741326

Tropism, pathology, and transmission of equine parvovirus-hepatitis.

Abstract: Equine parvovirus-hepatitis (EqPV-H) has recently been associated with cases of Theiler's disease, a form of fulminant hepatic necrosis in horses. To assess whether EqPV-H is the cause of Theiler's disease, we first demonstrated hepatotropism by PCR on tissues from acutely infected horses. We then experimentally inoculated horses with EqPV-H and 8 of 10 horses developed hepatitis. One horse showed clinical signs of liver failure. The onset of hepatitis was temporally associated with seroconversion and a decline in viremia. Liver histology and in situ hybridization showed lymphocytic infiltrates and necrotic EqPV-H-infected hepatocytes. We next investigated potential modes of transmission. Iatrogenic transmission via allogeneic stem cell therapy for orthopedic injuries was previously suggested in a case series of Theiler's disease, and was demonstrated here for the first time. Vertical transmission and mechanical vectoring by horse fly bites could not be demonstrated in this study, potentially due to limited sample size. We found EqPV-H shedding in oral and nasal secretions, and in feces. Importantly, we could demonstrate EqPV-H transmission via oral inoculation with viremic serum. Together, our findings provide additional information that EqPV-H is the likely cause of Theiler's disease and that transmission of EqPV-H occurs via both iatrogenic and natural routes.
Publication Date: 2020-03-20 PubMed ID: 32192415PubMed Central: PMC7144241DOI: 10.1080/22221751.2020.1741326Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study investigates the pathology, transmission, and tropism of equine parvovirus-hepatitis (EqPV-H), a virus associated with Theiler’s disease, a severe liver condition in horses. The study confirms the hepatotropism of EqPV-H and its transmission, both iatrogenically through stem cell therapy for orthopedic injuries and naturally, as evidenced by EqPV-H shedding in oral, nasal secretions and feces.

Investigating Hepatotropism of EqPV-H

  • The study begins by exploring the ‘tropism’ or the specificity of EqPV-H to liver cells. The process involved the use of PCR (polymerase chain reaction), a standard lab technique for amplifying DNA.
  • PCR was performed on tissue samples obtained from acutely infected horses which demonstrated the hepatotropism of EqPV-H, confirming that the virus chiefly invades and affects liver cells.

Experimenting with EqPV-H Inoculations

  • The researchers then inoculated horses with EqPV-H to emulate an infection. The response was observed through the onset of hepatitis in 8 out of 10 horses.
  • One horse demonstrated clinical signs of liver failure, implying severe viral invasion.
  • The initiation of hepatitis was associated with the process of seroconversion (antibody development) and a decline in viremia (virus presence in the bloodstream).
  • Examination of liver histology revealed lymphocytic infiltrates and the presence of necrotic EqPV-H-infected hepatocytes, further confirming the hepatotropic nature of EqPV-H.

Investigating Transmission Modes

  • The study also examined possible transmission modes. A previous case series suggested iatrogenic transmission (related to medical activities) through allogeneic stem cell therapy, a treatment used for orthopedic injuries, which was confirmed in this study.
  • However, vertical transmission (from mother to offspring) and mechanical vectoring (through horse flies) couldn’t be proved to contribute to the spread of the disease, possibly due to the limited sample size used.
  • The researchers also found evidence of EqPV-H shedding through oral and nasal secretions, and in feces.
  • Importantly, the team demonstrated EqPV-H transmission via oral inoculation with viremic serum, providing evidence of a natural transmission route.

Conclusion of the Study

  • In conclusion, this study adds evidence to the claim that EqPV-H is the likely cause of Theiler’s disease.
  • It was revealed that the transmission of EqPV-H occurs via both iatrogenic and natural routes, which is crucial information for preventing the spread of Theiler’s disease.

Cite This Article

APA
Tomlinson JE, Jager M, Struzyna A, Laverack M, Fortier LA, Dubovi E, Foil LD, Burbelo PD, Divers TJ, Van de Walle GR. (2020). Tropism, pathology, and transmission of equine parvovirus-hepatitis. Emerg Microbes Infect, 9(1), 651-663. https://doi.org/10.1080/22221751.2020.1741326

Publication

ISSN: 2222-1751
NlmUniqueID: 101594885
Country: United States
Language: English
Volume: 9
Issue: 1
Pages: 651-663

Researcher Affiliations

Tomlinson, Joy Ellen
  • Baker Institute for Animal Health, Cornell University College of Veterinary Medicine, Ithaca, NY, USA.
Jager, Mason
  • Baker Institute for Animal Health, Cornell University College of Veterinary Medicine, Ithaca, NY, USA.
Struzyna, Alyssa
  • Walnridge Equine Clinic, Cream Ridge, NJ, USA.
Laverack, Melissa
  • New York State Animal Health Diagnostic Center, Cornell University College of Veterinary Medicine, Ithaca, NY, USA.
Fortier, Lisa Ann
  • Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY, USA.
Dubovi, Edward
  • New York State Animal Health Diagnostic Center, Cornell University College of Veterinary Medicine, Ithaca, NY, USA.
Foil, Lane D
  • Entomology Department, Louisiana State University, Baton Rouge, LA, USA.
Burbelo, Peter D
  • Dental Clinical Research Core, National Institute of Dental and Craniofacial Research, National Institute of Health, Bethesda, MD, USA.
Divers, Thomas J
  • Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY, USA.
Van de Walle, Gerlinde R
  • Baker Institute for Animal Health, Cornell University College of Veterinary Medicine, Ithaca, NY, USA.

MeSH Terms

  • Animals
  • Diptera / virology
  • Feces / virology
  • Female
  • Hepatitis, Viral, Animal / pathology
  • Hepatitis, Viral, Animal / transmission
  • Hepatitis, Viral, Animal / virology
  • Hepatocytes / pathology
  • Hepatocytes / virology
  • Horse Diseases / pathology
  • Horse Diseases / transmission
  • Horse Diseases / virology
  • Horses
  • Infectious Disease Transmission, Vertical
  • Insect Vectors / virology
  • Liver / pathology
  • Liver / virology
  • Lymphocytes
  • Male
  • Mesenchymal Stem Cell Transplantation
  • Mesenchymal Stem Cells / virology
  • Mouth / virology
  • Necrosis
  • Parvoviridae Infections / pathology
  • Parvoviridae Infections / transmission
  • Parvoviridae Infections / veterinary
  • Parvoviridae Infections / virology
  • Parvovirus / isolation & purification
  • Parvovirus / pathogenicity
  • Parvovirus / physiology
  • Viral Tropism
  • Viremia
  • Virus Shedding

Grant Funding

  • K08 AI141767 / NIAID NIH HHS

Conflict of Interest Statement

No potential conflict of interest was reported by the author(s).

References

This article includes 34 references
  1. Divers TJ, Tennant BC, Kumar A. A new parvovirus associated with serum hepatitis in horses following inoculation of a common equine biological. Emerg Infect Dis 2018;24:303–310.
    doi: 10.3201/eid2402.171031pmc: PMC5782890pubmed: 29350162google scholar: lookup
  2. Tomlinson JE, Tennant B, Struzyna A. Viral testing of 10 cases of Theiler’s disease and 37 in-contact horses in the absence of equine biologic product administration: a prospective study (2014-2018). J Vet Intern Med 2019;33:258–265.
    doi: 10.1111/jvim.15362pmc: PMC6335540pubmed: 30520132google scholar: lookup
  3. Ramsay JD, Evanoff R, Mealey RH. The prevalence of elevated gamma-glutamyltransferase and sorbitol dehydrogenase activity in racing Thoroughbreds and their associations with viral infection. Equine Vet J 2019;51:738–742.
    doi: 10.1111/evj.13092pubmed: 30849186google scholar: lookup
  4. Lu G, Sun L, Ou J. Identification and genetic characterization of a novel parvovirus associated with serum hepatitis in horses in China. Emerg Microbes Infect 2018;7:170.
    pmc: PMC6198012pubmed: 30348940
  5. Meister TL, Tegtmeyer B, Brüggemann Y. Characterization of equine parvovirus in thoroughbred breeding horses from Germany. Viruses 2019;11:965.
    doi: 10.3390/v11100965pmc: PMC6833105pubmed: 31635426google scholar: lookup
  6. Altan E, Li Y, Sabino-Santos GS Jr. Viruses in horses with neurologic and respiratory diseases. Viruses 2019;11:942.
    doi: 10.3390/v11100942pmc: PMC6832430pubmed: 31614994google scholar: lookup
  7. Tomlinson JE, Kapoor A, Kumar A. Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014–2018). J Vet Intern Med 2019;33:251–257.
    doi: 10.1111/jvim.15368pmc: PMC6335536pubmed: 30520162google scholar: lookup
  8. Cotmore SF, Tattersall P. Parvovirus DNA replication. 1996;p. 799–813.
  9. Verhoef JNC, Allen AL, Harding JCS. Metallothionein expression in horses with chronic liver disease and its correlation with Ki-67 immunoreactivity. Vet Pathol 2018;55:703–710.
    doi: 10.1177/0300985818777802pubmed: 29865992google scholar: lookup
  10. Tomlinson JE, Van de Walle GR, Divers TJ. What do we know about hepatitis viruses in horses?. Vet Clin North Am – Equine Pract 2019;35:351–362.
    doi: 10.1016/j.cveq.2019.03.001pubmed: 31084975google scholar: lookup
  11. Theiler A. Acute liver-atrophy and parenchymatous hepatitis in horses. Union South Africa Dept Agric 5th 6th Repts Dir Vet Res 1918.
  12. Burbelo PD, Dubovi EJ, Simmonds P. Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol 2012;86:6171–6178.
    doi: 10.1128/JVI.00250-12pmc: PMC3372197pubmed: 22491452google scholar: lookup
  13. Bourzac C, Smith LC, Vincent P. Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols. Equine Vet J 2010;42:519–527.
  14. Watts AE, Nixon AJ, Yeager AE. A collagenase gel/physical defect model for controlled induction of superficial digital flexor tendonitis. Equine Vet J 2012;44:576–586.
  15. Corcioli F, Zakrzewska K, Rinieri A. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J Med Virol 2008;80:2005–2011.
    doi: 10.1002/jmv.21289pubmed: 18814251google scholar: lookup
  16. Söderlund-Venermo M, Hokynar K, Nieminen J. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris) 2002;50:307–316.
    doi: 10.1016/S0369-8114(02)00307-3pubmed: 12116849google scholar: lookup
  17. Norja P, Hokynar K, Aaltonen LM. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U. S. A. 2006;103:7450–7453.
    doi: 10.1073/pnas.0602259103pmc: PMC1464359pubmed: 16651522google scholar: lookup
  18. Cotmore SF, Tattersall P. Parvovirus diversity and DNA damage responses. Cold Spring Harb Perspect Biol 2013;5:1–12.
    doi: 10.1101/cshperspect.a012989pmc: PMC3552509pubmed: 23293137google scholar: lookup
  19. Gugjoo MB, Amarpal, Makhdoomi DM. Equine mesenchymal stem cells: properties, sources, characterization, and potential therapeutic applications. J Equine Vet Sci 2019;72:16–27.
    doi: 10.1016/j.jevs.2018.10.007pubmed: 30929778google scholar: lookup
  20. Puccetti C, Contoli M, Bonvicini F. Parvovirus B19 in pregnancy: possible consequences of vertical transmission. Prenat Diagn 2012;32:897–902.
    pubmed: 22777688
  21. Miao LF, Zhang CF, Chen CM. Real-time PCR to detect and analyze virulent PPV loads in artificially challenged sows and their fetuses. Vet Microbiol 2009;138:145–149.
    doi: 10.1016/j.vetmic.2009.02.006pubmed: 19345523google scholar: lookup
  22. Foil LD, Adams WV, Mcmanus JM. Bloodmeal residues on mouthparts of Tabanus fuscicostatus (Diptera : Tabanidae) and the potential for mechanical transmission of pathogens. J Med Entomol 1987;24:613–616.
    doi: 10.1093/jmedent/24.6.613pubmed: 2826787google scholar: lookup
  23. Gather T, Walter S, Todt D. Vertical transmission of hepatitis C virus-like nonprimate hepacivirus in horses. J Gen Virol 2016;97:2540–2551.
    doi: 10.1099/jgv.0.000561pubmed: 27461949google scholar: lookup
  24. Pusterla N, Conrad PA, Packham AE. Endogenous transplacental transmission of Neospora hughesi in naturally infected horses. J Parasitol 2011;97:281–285.
    doi: 10.1645/GE-2657.1pubmed: 21506870google scholar: lookup
  25. Mims CA. Vertical transmission of viruses. Microbiol Rev 1981;45:267–286.
  26. Chavatte-Palmer P, Tarrade A. Placentation in different mammalian species. Ann Endocrinol (Paris) 2016;77:67–74.
    doi: 10.1016/j.ando.2016.04.006pubmed: 27155775google scholar: lookup
  27. Arora N, Sadovsky Y, Dermody TS. Microbial vertical transmission during human Pregnancy. Cell Host Microbe 2017;21:561–567.
    doi: 10.1016/j.chom.2017.04.007pmc: PMC6148370pubmed: 28494237google scholar: lookup
  28. Tidwell MA, Dean WD, Tidwell MA. Transmission of Hog cholera virus by Horseflies (Tabanidae: Diptera). Am J Vet Res 1972;33:615–622.
    pubmed: 4401263
  29. Hawkins JA, Adams WV Jr, Wilson BH. Transmission of equine infectious anemia virus by Tabanus fuscicostatus. JAVMA 1976;168:63–64.
    pubmed: 942712
  30. Foil LD, Seger CL, French DD. Mechanical transmission of bovine leukemia virus by horse flies (Diptera : Tabanidae). J Med Entomol 1988;25:374–376.
    doi: 10.1093/jmedent/25.5.374pubmed: 2848127google scholar: lookup
  31. Goddard A, Leisewitz AL, Goddard A. Canine parvovirus. Vet Clin NA Small Anim Pract 2010;40:1041–1053.
    doi: 10.1016/j.cvsm.2010.07.007pubmed: 20933134google scholar: lookup
  32. Foerster T, Streck AF, Speck S. An inactivated whole-virus porcine parvovirus vaccine protects pigs against disease but does not prevent virus shedding even after homologous virus challenge. J Gen Virol 2016;97:1408–1413.
    doi: 10.1099/jgv.0.000446pubmed: 26939976google scholar: lookup
  33. Roberts PL, Hart H. Comparison of the inactivation of canine and bovine parvovirus by freeze-drying and dry-heat treatment in two high purity factor VIII concentrates. Biologicals 2000;28:185–188.
    doi: 10.1006/biol.2000.0256pubmed: 10964445google scholar: lookup
  34. Mani B, Gerber M, Lieby P. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses. Transfusion 2007;47:1765–1774.

Citations

This article has been cited 24 times.
  1. Jager MC, Luethy D, Shallop S, Cathcart J, Divers TJ, Tan JY, Beasley EM, Johnson P, Leduc L, Smith C, Jamieson CA, Magdesian KG, Van de Walle GR, Tomlinson JE. Chronic hepatitis in horses with persistent equine hepacivirus infection. Equine Vet J 2026 Mar;58(2):444-457.
    doi: 10.1111/evj.70124pubmed: 41448947google scholar: lookup
  2. Scupham AJ, Tong C. Detection of equine parvovirus-hepatitis and efficacy of governmental regulation for equine biologics purity. J Vet Diagn Invest 2025 Jan;37(1):79-85.
    doi: 10.1177/10406387241292343pubmed: 39506428google scholar: lookup
  3. Fortier C, El-Hage C, Normand C, Hue ES, Sutton G, Marcillaud-Pitel C, Jeffers K, Bamford N, Oden E, Paillot R, Hartley C, Gilkerson J, Pronost S. Detection of Equine Parvovirus-Hepatitis Virus and Equine Hepacivirus in Archived Sera from Horses in France and Australia. Viruses 2024 May 28;16(6).
    doi: 10.3390/v16060862pubmed: 38932156google scholar: lookup
  4. Jager MC, Choi E, Tomlinson JE, Van de Walle G. Naturally acquired equine parvovirus-hepatitis is associated with a wide range of hepatic lesions in horses. Vet Pathol 2024 May;61(3):442-452.
    doi: 10.1177/03009858231214024pubmed: 38018088google scholar: lookup
  5. Papapetrou MA, Arroyo LG, Meister TL, Baird JD, Steinmann E, Lillie BN. Prevalence of equine parvovirus-hepatitis in healthy broodmares in Ontario, Canada. Can J Vet Res 2023 Jul;87(3):169-175.
    pubmed: 37397641
  6. Ho A, Orton R, Tayler R, Asamaphan P, Herder V, Davis C, Tong L, Smollett K, Manali M, Allan J, Rawlik K, McDonald SE, Vink E, Pollock L, Gannon L, Evans C, McMenamin J, Roy K, Marsh K, Divala T, Holden MTG, Lockhart M, Yirrell D, Currie S, O'Leary M, Henderson D, Shepherd SJ, Jackson C, Gunson R, MacLean A, McInnes N, Bradley-Stewart A, Battle R, Hollenbach JA, Henderson P, Odam M, Chikowore P, Oosthuyzen W, Chand M, Hamilton MS, Estrada-Rivadeneyra D, Levin M, Avramidis N, Pairo-Castineira E, Vitart V, Wilkie C, Palmarini M, Ray S, Robertson DL, da Silva Filipe A, Willett BJ, Breuer J, Semple MG, Turner D, Baillie JK, Thomson EC. Adeno-associated virus 2 infection in children with non-A-E hepatitis. Nature 2023 May;617(7961):555-563.
    doi: 10.1038/s41586-023-05948-2pubmed: 36996873google scholar: lookup
  7. Ou J, Li J, Wang X, Zhong L, Xu L, Xie J, Lu G, Li S. Genetic characterization of three recently discovered parvoviruses circulating in equines in China. Front Vet Sci 2022;9:1033107.
    doi: 10.3389/fvets.2022.1033107pubmed: 36570511google scholar: lookup
  8. Pezzanite LM, Chow L, Phillips J, Griffenhagen GM, Moore AR, Schaer TP, Engiles JB, Werpy N, Gilbertie J, Schnabel LV, Antczak D, Miller D, Dow S, Goodrich LR. TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant Staphylococcal septic arthritis in an equine model. Ann Transl Med 2022 Nov;10(21):1157.
    doi: 10.21037/atm-22-1746pubmed: 36467344google scholar: lookup
  9. Jager MC, Tomlinson JE, Henry CE, Fahey MJ, Van de Walle GR. Prevalence and pathology of equine parvovirus-hepatitis in racehorses from New York racetracks. Virol J 2022 Nov 1;19(1):175.
    doi: 10.1186/s12985-022-01901-3pubmed: 36320007google scholar: lookup
  10. Tomlinson JE, Van de Walle GR. Nasal transmission of equine parvovirus hepatitis. J Vet Intern Med 2022 Nov;36(6):2238-2244.
    doi: 10.1111/jvim.16569pubmed: 36250682google scholar: lookup
  11. Mashin VV, Sergeev AN, Martynova NN, Sergeev AA, Lys'ko KA, Raikov AO, Kataeva VV, Zagidullin NV. Viral Safety Issues in the Production and Manufacturing of Human Immunoglobulin Preparations from Equine Plasma/Serum. Pharm Chem J 2022;56(4):532-537.
    doi: 10.1007/s11094-022-02675-2pubmed: 35845147google scholar: lookup
  12. Satué K, Miguel-Pastor L, Chicharro D, Gardón JC. Hepatic Enzyme Profile in Horses. Animals (Basel) 2022 Mar 29;12(7).
    doi: 10.3390/ani12070861pubmed: 35405850google scholar: lookup
  13. Lee SK, Park D, Lee I. Molecular Prevalence of Equine Parvovirus-Hepatitis in the Sera of Clinically Healthy Horses in South Korea. Vet Sci 2021 Nov 19;8(11).
    doi: 10.3390/vetsci8110282pubmed: 34822655google scholar: lookup
  14. Yoon J, Park T, Kim A, Song H, Park BJ, Ahn HS, Go HJ, Kim DH, Lee JB, Park SY, Song CS, Lee SW, Choi IS. First Detection and Genetic Characterization of New Equine Parvovirus Species Circulating among Horses in Korea. Vet Sci 2021 Nov 7;8(11).
    doi: 10.3390/vetsci8110268pubmed: 34822641google scholar: lookup
  15. Yoon J, Park T, Kim A, Park J, Park BJ, Ahn HS, Go HJ, Kim DH, Jung S, Seo Y, Lee JB, Park SY, Song CS, Lee SW, Choi IS. First Clinical Case of Equine Parvovirus-Hepatitis-Related Theiler's Disease in Asia. Viruses 2021 Sep 24;13(10).
    doi: 10.3390/v13101917pubmed: 34696347google scholar: lookup
  16. Jager MC, Tomlinson JE, Lopez-Astacio RA, Parrish CR, Van de Walle GR. Small but mighty: old and new parvoviruses of veterinary significance. Virol J 2021 Oct 24;18(1):210.
    doi: 10.1186/s12985-021-01677-ypubmed: 34689822google scholar: lookup
  17. Pusterla N, James K, Barnum S, Delwart E. Investigation of Three Newly Identified Equine Parvoviruses in Blood and Nasal Fluid Samples of Clinically Healthy Horses and Horses with Acute Onset of Respiratory Disease. Animals (Basel) 2021 Oct 19;11(10).
    doi: 10.3390/ani11103006pubmed: 34680025google scholar: lookup
  18. Altan E, Hui A, Li Y, Pesavento P, Asín J, Crossley B, Deng X, Uzal FA, Delwart E. New Parvoviruses and Picornavirus in Tissues and Feces of Foals with Interstitial Pneumonia. Viruses 2021 Aug 14;13(8).
    doi: 10.3390/v13081612pubmed: 34452477google scholar: lookup
  19. Zehetner V, Cavalleri JV, Klang A, Hofer M, Preining I, Steinborn R, Ramsauer AS. Equine Parvovirus-Hepatitis Screening in Horses and Donkeys with Histopathologic Liver Abnormalities. Viruses 2021 Aug 12;13(8).
    doi: 10.3390/v13081599pubmed: 34452465google scholar: lookup
  20. Reinecke B, Klöhn M, Brüggemann Y, Kinast V, Todt D, Stang A, Badenhorst M, Koeppel K, Guthrie A, Groner U, Puff C, de le Roi M, Baumgärtner W, Cavalleri JV, Steinmann E. Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-Hepatitis. Viruses 2021 Jul 26;13(8).
    doi: 10.3390/v13081454pubmed: 34452320google scholar: lookup
  21. Ramsauer AS, Badenhorst M, Cavalleri JV. Equine parvovirus hepatitis. Equine Vet J 2021 Sep;53(5):886-894.
    doi: 10.1111/evj.13477pubmed: 34101906google scholar: lookup
  22. Hui A, Altan E, Slovis N, Fletcher C, Deng X, Delwart E. Circovirus in Blood of a Febrile Horse with Hepatitis. Viruses 2021 May 20;13(5).
    doi: 10.3390/v13050944pubmed: 34065502google scholar: lookup
  23. Badenhorst M, de Heus P, Auer A, Tegtmeyer B, Stang A, Dimmel K, Tichy A, Kubacki J, Bachofen C, Steinmann E, Cavalleri JMV. Active equine parvovirus-hepatitis infection is most frequently detected in Austrian horses of advanced age. Equine Vet J 2022 Mar;54(2):379-389.
    doi: 10.1111/evj.13444pubmed: 33704819google scholar: lookup
  24. Tomlinson JE, Wolfisberg R, Fahnøe U, Sharma H, Renshaw RW, Nielsen L, Nishiuchi E, Holm C, Dubovi E, Rosenberg BR, Tennant BC, Bukh J, Kapoor A, Divers TJ, Rice CM, Van de Walle GR, Scheel TKH. Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis. PLoS Pathog 2020 Jul;16(7):e1008677.
    doi: 10.1371/journal.ppat.1008677pubmed: 32649726google scholar: lookup